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Abstract
The hydroxylation of n-alkanes, which proceeds in the presence of a P450-monooxygenase advantageously at temperatures signifi-
cantly below room temperature, is described. In addition, an enzymatic hydroxylation of the “liquid gas” n-butane with in situ
cofactor regeneration, which does not require high-pressure conditions, was developed. The resulting 2-butanol was obtained as the
only regioisomer, at a product concentration of 0.16 g/L.
Introduction
The (regioselective) oxidative functionalization of nonfunction-
alized alkanes represents one of the most challenging types of
reactions that organic chemists currently face [1-3]. A particu-
lar challenge in this field is the functionalization of volatile
n-alkanes, which are present as gases under ambient conditions.
A short n-alkane molecule that fulfils these criteria, of (i) being
a gas at ambient temperature and pressure, and of (ii) being
regioselectively hydroxylated, is n-butane. This compound is
a so-called “liquid gas”, having a boiling point of −0.5 °C. A
regioselective hydroxylation would yield either 1- or 2-butanol,
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which are bulk chemicals currently produced by chemocatal-
ysis [4]. So far, reports on enzymatic functionalization of the
liquid gas n-butane are rare, although some monohydroxyla-
tions were reported by various groups, leading to 1-butanol and
2-butanol with different product distributions [5-9]. When a
methane monooxygenase from Methylocystis sp. was used, a
ratio of 58:42 was obtained for the product isomers 1- and 2-bu-
tanol, respectively [7]. However, use of the hydroxylase unit
only, in combination with hydrogen peroxide, furnished exclu-
sively 2-butanol. A perfect regioselectivity of 100% for 2-buta-
nol was reported by the group of Arnold using a P450-mono-
oxygenase BM-3 mutant [8]. Recently, Reetz et al. reported a
remarkable improvement when using a perfluoro carboxylic
acid as an additive, thereby accelerating the hydroxylation as
catalyzed by a P450-monooxygenase BM-3 mutant in combina-
tion with high pressure (10 bar) at 25 °C [9]. So far most
hydroxylations of n-butane were performed without in situ
cofactor regeneration, which is, however, a prerequisite for a
synthetically useful process [10]. An exception is the recently
reported process by Reetz et al. [9], which is based on the use of
a glucose dehydrogenase and D-glucose as a cheap cosubstrate
for in situ cofactor regeneration. Independently, in our work we
focused on a biocatalytic hydroxylation of n-butane, which also
proceeds with this type of in situ cofactor regeneration but does
not require high-pressure conditions. In particular, we were
interested in a practical experimental setup in which n-butane is
utilized directly in liquid form (Scheme 1), and thus can be
applied easily in laboratories without high-pressure equipment.
In the following we report such a process.
Scheme 1: Biocatalytic n-butane hydroxylation with enzymatic in situ
cofactor regeneration.
For in situ cofactor regeneration in this regioselective hydroxy-
lation of n-butane to 2-butanol in the absence of high-pressure
conditions, the well-established glucose dehydrogenase/
D-glucose cofactor regeneration system was chosen due to the
successful use of this method on an industrial scale in several
redox applications [11,12]. Since its low boiling point (−0.5 °C)
represents a particular challenge for the preparative hydroxyla-
tion of n-butane, we became interested in the development of a
biocatalytic hydroxylation that can be carried out at tempera-
tures significantly below room temperature. This would limit
the removal of n-butane into the gas phase, thus keeping the
overall concentration of n-butane in the liquid phase at a reason-
able level (at least over a certain period of time, which is depen-
dent also on the volume of the gas phase).
Results and Discussion
For our initial study of the ability of the P450-monooxygenase
to exhibit sufficient activity even at a decreased reaction
temperature, we used n-octane as a model substrate due to its
higher boiling point and easier handling compared to n-butane.
As a catalyst for the hydroxylation a P450-monooxygenase
mutant of BM-3 (F87V) was used [13-16], and the in situ
cofactor regeneration was conducted with a commercially avail-
able glucose dehydrogenase. This enzyme converts D-glucose
into D-gluconolactone (which is then hydrolyzed in situ to
D-gluconic acid), thus regenerating the reduced cofactor
NADPH required for the hydroxylation step (Scheme 2).
Scheme 2: Biocatalytic n-octane hydroxylation with enzymatic in situ
cofactor regeneration.
As a benchmark reaction we carried out this transformation at
room temperature (on 5 mL scale with 10 mol % of NADP+),
forming 0.42 g/L of octanol isomers (Table 1, entry 1).
The determination of the product concentration appeared to be a
more reliable parameter to characterize the performance of the
hydroxylation reaction, compared with the conversion due to
evaporation of n-octane from the reaction mixture during the
reaction. Using a decreased cofactor amount of 2 mol % gave a
comparable performance resulting in 0.41 g/L of octane isomers
(Table 1, entry 2). Notably, when starting this reaction at a
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Table 1: Influence of reaction temperature and amount of cofactor on
the enzymatic hydroxylation of n-octane.
Entry NADP+
(mol %)
reaction temperature product conc.
(g/L)a
1 10 rtb 0.42
2 2 rtb 0.41
3 2 8 °Cc 0.47
aProduct concentration refers to 2-octanol and other octanol isomers;
brt = room temperature for 24 h; c8 °C for 8 h, then slow warm up to rt
within the following 16 h.
decreased temperature of 8 °C an increased formation of
octanol isomers of 0.47 g/L was observed (Table 1, entries 2
and 3). This clearly indicates that P450 BM-3-type monooxyge-
nases operate suitably at low temperature, thus offering interest-
ing perspectives for applications with liquid gases.
Encouraged by these results we then focused on the hydroxyla-
tion of the so-called “liquid gas” n-butane (boiling point:
−0.5 °C), at a low starting temperature, which was chosen in the
range of −5 to 8 °C. For the biotransformation of this liquid gas
the following experimental procedure was carried out: First, all
components required for the reaction (in a particular solvent)
were cooled and then transferred into a precooled reaction flask.
Subsequently, n-butane was added from a lecture bottle as the
final component, and the reaction flask was sealed. The reac-
tion mixture was kept at a given reaction temperature for 8 h,
followed by a slow warm-up to room temperature within the
following 16 h. In one experiment at 0 °C the work-up was
directly carried out without a warm-up of the reaction mixture.
As a P450-monooxygenase, the 19A12-mutant of the BM-3
enzyme was used, since this enzyme was reproted to be suit-
able for short-chain n-alkanes [8]. Once again, a glucose dehy-
drogenase from Bacillus sp. was used for enzymatic cofactor
regeneration (according to the reaction concept shown in
Scheme 1) in the presence of 0.09 mol % of NADP+ as a
cofactor (Scheme 3).
When the reaction was conducted at room temperature, as a
benchmark process, a product formation of 0.06 g/L of 2-buta-
nol as the only regioisomer was observed (Table 2, entry 1).
Interestingly, we found a remarkable improvement in the prod-
uct formation with concentrations of 0.10 g/L and 0.16 g/L
achieved when lowering the initial reaction temperature signifi-
cantly to 8 °C and 0 °C, respectively, for 8 h (Table 2, entries 2
and 3). These results, jointly with an experiment at 0 °C
involving direct work-up without warm-up to room tempera-
ture (Table 2, entry 4), underline that the applied P450-mono-
oxygenase mutant retains sufficient activity even at low reac-
Scheme 3: Enzymatic hydroxylation of n-butane (used as liquid) with
in situ cofactor regeneration.
Table 2: Enzymatic hydroxylation of n-butane.
Entry reaction temperature product conc. of 2 (g/L)a
1 rtb 0.06
2 8 °Cc 0.10
3 0 °Cc 0.16
4 0 °Cd 0.14
5 −1/−2 °Cc 0.13
6 −5 °Cc 0.04
aProduct concentration refers to 2-butanol as the only regioisomer
observed; brt = room temperature for 24 h; cthis reaction temperature
was maintained for 8 h, followed by a slow warm-up to rt within the
following 16 h; d0 °C for 8 h, then direct work-up.
tion temperatures of 0 °C and 8 °C (Table 2, entries 2–4). When
the reaction temperature was lowered further, to −1/−2 °C and
−5 °C, less satisfactory results were obtained (Table 2, entries 5
and 6). An explanation for these lower product formations may
be due to the highly viscous and frozen reaction mixtures that
were obtained at −1/−2 °C and −5 °C. In order to make sure that
this result was not in fact due to a loss of activity of the glucose
dehydrogenase from Bacillus sp. at low temperatures, the
activity of this enzyme was determined at −10 °C (40 vol % of
glycerol) and at −5 °C (30 vol % of glycerol). In this study, the
glucose dehydrogenase showed a high remaining activity of
81% at −10 °C and an activity of 82% at −5 °C after 24 h of
stirring. Thus, the current optimized process for the desired
hydroxylation of n-butane is based on a reaction temperature of
0 °C for 8 h, followed by a slow warm-up to room temperature
(within the subsequent 16 h), which gives exclusively 2-buta-
nol as the only regioisomer at a product concentration of
0.16 g/L (Table 2, entry 3).
Beilstein J. Org. Chem. 2012, 8, 186–191.
189
Conclusion
In conclusion, the use of P450-monooxygenases in the hydroxy-
lation of n-alkanes, which proceeds advantageously at
decreased reaction temperatures, has been reported. In addition,
a biocatalytic oxidation of n-butane, as a representative example
for a “liquid gas”, was carried out with enzymatic in situ
cofactor regeneration and without the need for high-pressure
conditions, in a highly regioselective fashion. This process,
running at an initial reaction temperature of 0 °C, led exclu-
sively to the formation of 2-butanol as the only regioisomer, at a
product concentration of 0.16 g/L. The practical experimental
setup of this process allows the direct use of n-butane, which
has a boiling point of −0.5 °C, in liquid form and can be easily
applied in laboratories lacking high-pressure equipment. A
current challenge, addressed in our laboratories, is the further
improvement of process efficiency and volumetric productivity
of this enzymatic oxidation process. In addition, studies of
enzyme stability during this biotransformation process are
planned as future work.
Experimental
Bacterial strains and expression vectors
The expression strains used in this work are E. coli DH5α
pCWori P450 BM-3 F87V [16] and E. coli BL21 Gold (DE3)
lacIQ1 P450 BM-3 19A12 (this work).
Construction of the P450-monooxygenase BM-3
19A12 expression system
The heme domain of the P450-monooxygenase BM-3 19A12
variant [17] was purchased as synthetic DNA (Life Tech-
nologies, Darmstadt, Germany) and subcloned into the
pET28a(+)-derived pALXtreme-1a vector, harbouring the wild-
type P450 BM-3 gene from Bacillus megaterium (CYP102A1)
[18]. For the purpose of replacing the wild-type heme domain
of P450-monooxygenase BM-3, both the synthetic DNA and
vector were cut for 1 h with 1 U each of FastDigest® endonu-
cleases NcoI and MssI (Fermentas, St. Leon-Rot Germany) and
purified by gel extraction (NucleoSpin® Gel Clean up,
Macherey-Nagel, Düren, Germany). A ligation reaction was
performed with the T4 DNA Ligase (Fermentas, St. Leon-Rot
Germany) according to the manufacturer’s instructions. The
ligation reaction was subsequently transformed into chemically
competent E. coli BL21 Gold (DE3) lacIQ1 cells [18], which
were prepared by following a standard protocol [19]. For the
chemically competent cells a transformation efficiency of
1 × 107 cfu/µg pUC19 was determined.
Expression and isolation of the P450-monooxygen-
ase BM-3 F87V and 19A12 variants
Both P450-monooxygenase BM-3 variants, P450-monooxygen-
ase BM-3 F87V and P450-monooxygenase BM-3 19A12, were
expressed in 2 L shaking flasks containing 400 mL TB expres-
sion media, which was supplemented with 400 µL trace
elements (0.64 µM CuSO4, 0.69 µM ZnSO4, 0.72 µM MnSO4,
0.76 µM CoCl2, 59.43 µM Na2-EDTA, 61.79 µM FeCl3) and
the respective antibiotic (for E. coli DH5α, harbouring pCWori,
100 µg/mL ampicillin and for E. coli BL21 Gold (DE3) LacIQ1,
harbouring pALXtreme-1a, 50 µg/mL kanamycin). Cultivation,
induction and expression were performed as previously
described [20]. E. coli cells were harvested by centrifugation
(10 min, 2900 g at 4 °C) and cell pellets were washed in 50 mM
KPi buffer (pH 7.0), and stored at −20 °C overnight. For prepar-
ation of crude cell extracts, frozen cell pellets were resus-
pended in 50 mM KPi buffer (pH 7.0) prior to disruption with
an Avestin EmulsiFlex-C3 high-pressure homogenizer (Ottawa,
ON, Canada) by applying three cycles of 1500 bar. The lysate
was centrifuged (30 min, 16000 g at 4 °C) in a Sorvall RC-6
Plus centrifuge (Thermo Scientific, Rockford, IL, USA) and
further clarified by filtration through a 0.45 µm filter (Roth,
Karlsruhe, Germany). Subsequently, crude cell extracts were
shock-frozen in liquid nitrogen, lyophilized for 48 h at −54 °C
in an Alpha 1-2 LD plus Freeze dryer (Christ, Osterode am
Harz, Germany) and stored at −20 °C until further use.
Typical procedure for the hydroxylation of
n-octane with in situ cofactor regeneration
(according to the reactions described in
Table 1)
To 5 mL of phosphate buffer (pH 7.0, 50 mM) in a 10 mL flask,
the F87V-mutant of P450-monooxygenase BM-3 (3.82 U; refer-
ring to the activity of n-octane), n-octane (16.3 µL; 0.1 mmol),
D-glucose (90.1 mg; 0.5 mmol) and glucose dehydrogenase
from Bacillus sp. (Amano Enzyme Inc.; 18 U referring to the
activity for D-glucose) were added. After 20 min of stirring at rt
or 8 °C, the reaction was started by the addition of 2 mol %
(1.48 mg) or 10 mol % (7.44 mg) of NADP+. The mixture was
stirred in a sealed flask for 24 h at rt, or for 8 h at 8 °C, fol-
lowed by a slow warm-up to rt in the subsequent 16 h. Then,
pyridine (0.3 mmol) was added as an external standard to the
reaction mixture. For the work-up step the aqueous reaction
mixture was subdivided into five portions. Each of them (1 mL)
was filled into a 2 mL Eppendorf vial and extracted with meth-
ylene chloride (1 mL; by shaking the vials in a thermomixer at
25 °C for 30 min and removal of the aqueous layers with a
syringe). The work-up step was repeated twice. In total, the
aqueous layers were extracted three times with methylene chlo-
ride (3 × 5 mL). The organic and aqueous layers were sep-
arated by centrifugation for 30 min at 13.000 rpm. Afterwards
the aqueous layers were removed by a syringe and the
combined organic layers were evaporated at 900 mbar and
40 °C for about 30 min under vacuum. The amount of the
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formed product (in g of octanol isomers per L of reaction
volume) was determined by 1H NMR spectroscopy and from
the output weight of the crude product, or by 1H NMR spec-
troscopy in comparison with the quantity of the external stan-
dard.
Typical procedure for the hydroxylation of
n-butane with in situ cofactor regeneration
(according to the reactions described in
Table 2)
To 10 mL of cooled phosphate buffer (pH 7.0, 50 mM) in a
cooled 100 mL flask, the 19A12-mutant of P450-monooxygen-
ase BM-3 (3.82 U; referring to the activity of n-heptane),
D-glucose (90.1 mg; 0.5 mmol), glucose dehydrogenase from
Bacillus sp. (Amano Enzyme Inc.; 18 U referring to the activity
for D-glucose) and NADP+ (1.48 mg; 0.002 mmol) were added.
Immediately after n-butane was filled into the flask from a
lecture bottle (entry 1: 163 mg; entry 2: 185 mg; entry 3:
175 mg; entry 4: 246 mg; entry 5: 323 mg; entry 6: 435 mg), the
flask was sealed and the mixture was stirred in the sealed flask
for 24 h at rt (entry 1), or for 8 h at a reaction temperature in the
range of −5 °C to 8°C (entries 2–6), followed in most cases by a
slow warm-up to rt in the subsequent 16 h (entries 2,3,5,6). The
work-up was carried out as described above in the typical
procedure for the hydroxylation of n-octane, with the excep-
tions that pyridine was not added and that the combined organic
layers were evaporated at 900 mbar and 40 °C for about 40 min.
The amount of formed product (in g of 2-butanol per L of reac-
tion volume) was determined by 1H NMR spectroscopy and
from the output weight of the crude product.
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